Advantages of Computerized Dosing Strategy in Tacrolimus Treatment of Renal Transplant Patients.

被引：0
|
作者：
Kim, S. -Y. [1 ]
Cho, S. [1 ]
Cho, M. -J. [1 ]
Lee, C. [1 ]
Han, A. [1 ]
Choi, C. [1 ]
Ahn, S. [1 ]
Min, S. -I. [1 ]
Min, S. -K. [1 ]
Park, M. [2 ]
Jung, I. [3 ]
Kim, S. [4 ]
Ha, J. [1 ,2 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea
[2] Korea Organ Donat Agcy, Seoul, South Korea
[3] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Surg, Seoul, South Korea
[4] Myoungji Hosp, Dept Surg, Goyang Si, South Korea
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B121
引用
收藏
页码：539 / 539
页数：1
相关论文
共 50 条
  • [1] Dosing and management guidelines for tacrolimus in renal transplant patients
    van Hooff, JP
    Boots, JMM
    van Duijnhoven, EM
    Christiaans, MHL
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (7A) : 54S - 57S
  • [2] Pharmacokinetics of oral tacrolimus in pediatric renal transplant patients.
    Simon, DH
    Aviles, DH
    Silverstein, D
    Vehaskari, VM
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S303 - S303
  • [3] PHARMACOLOGICAL EVALUATION OF A REDUCED DOSING STRATEGY OF MYCOPHENOLATE MOFETIL IN TACROLIMUS-TREATED RENAL TRANSPLANT PATIENTS
    Chabroux-Seffert, Aline
    Maillard, Nicolas
    Delavenne, Xavier
    Basset, Thierry
    Alamartine, Eric
    Mariat, Christophe
    TRANSPLANT INTERNATIONAL, 2012, 25 : 54 - 54
  • [4] PHARMACOLOGICAL EVALUATION OF A REDUCED DOSING STRATEGY OF MYCOPHENOLATE MOFETIL IN TACROLIMUS-TREATED RENAL TRANSPLANT PATIENTS
    Aline, Chabroux Seffert
    Basset, Thierry
    Delavenne, Xavier
    Alamartine, Eric
    Mariat, Christophe
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 313 - 314
  • [5] Pharmacological Evaluation of a Reduced Dosing Strategy of Mycophenolate Mofetil in Tacrolimus-Treated Renal Transplant Patients
    Chabroux-Seffert, A.
    Basset, T.
    Delavenne, X.
    Alamartine, E.
    Mariat, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 115 - 116
  • [6] A limited sampling strategy for tacrolimus in renal transplant patients
    Mathew, Binu S.
    Fleming, Denise H.
    Jeyaseelan, Visalakshi
    Chandy, Sujith J.
    Annapandian, V. M.
    Subbanna, P. K.
    John, George T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (04) : 467 - 472
  • [7] Tacrolimus does not cause overgrowth of the gingiva in renal transplant patients.
    Klokkevold, PR
    Danovitch, GM
    Kendrick, E
    Wilkinson, AH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3324 - A3324
  • [8] Gingival treatment in renal transplant patients.
    Pistochini, A
    Raffo, ML
    Sousa, M
    Friedman, J
    Bordoni, N
    JOURNAL OF DENTAL RESEARCH, 1998, 77 (05) : 1110 - 1110
  • [9] Alemtuzumab Preconditioning and Tacrolimus Monotherapy in African American Renal Transplant Patients.
    Shapiro, Ron
    Odocha, Okay
    Basu, Amit
    Tan, Henkie P.
    Morgan, Claire
    Sharma, Vivek
    Blisard, Deanna
    Dvorchik, Igor
    Randhawa, Parmjeet S.
    McCauley, Jerry
    Zeevi, Adrianna
    Starzl, Thomas E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 678 - 678
  • [10] Significant Influence of Hematocrit on Tacrolimus Apparent Clearance in Renal Transplant Patients.
    Benkali, Khaled
    Premaud, Aurelie
    Rerolle, Jean-Philippe
    Hoizey, Guillaume
    Olivier, Toupance
    Villemain, Florence
    Turcant, Alain
    Le Meur, Yannick
    Marquet, Pierre
    Rousseau, Annick
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 500 - 501
12345